Orbimed Advisors LLC Chemomab Therapeutics Ltd. Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Orbimed Advisors LLC holds 2,241,274 shares of CMMB stock, worth $2.04 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,241,274
Previous 2,241,274
-0.0%
Holding current value
$2.04 Million
Previous $1.14 Million
52.93%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CMMB
# of Institutions
16Shares Held
2.66MCall Options Held
0Put Options Held
0-
Ikarian Capital, LLC Dallas, TX213KShares$194,1860.02% of portfolio
-
Two Sigma Investments, LP New York, NY40KShares$36,3940.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny37.8KShares$34,3980.0% of portfolio
-
Kestra Private Wealth Services, LLC31.2KShares$28,4290.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY26.5KShares$24,1410.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $10.4M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...